Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dupilumab 150 mg/mL solution for injection |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely dupilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely dupilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Secukinumab 150 mg/mL solution for injection |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Secukinumab 150 mg/mL solution for injection |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Fenfluramine 2.2 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Fenfluramine 2.2 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely bedaquiline (as bedaquiline fumarate) 20 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely bedaquiline (as bedaquiline fumarate) 20 milligram/1 each conventional release oral tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Bedaquiline (as bedaquiline fumarate) 100 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Bedaquiline (as bedaquiline fumarate) 100 mg oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Monomethyl fumarate 95 mg oral capsule |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Monomethyl fumarate 95 mg oral capsule |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Monomethyl fumarate only product |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Monomethyl fumarate only product in oral dose form |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
3 |
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
4 |
Product containing precisely elagolix sodium 300 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely elagolix sodium 300 milligram/1 each conventional release oral capsule (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
3 |
Clostridium histolyticum-kollagenas 900 mikrog/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Clostridium histolyticum-kollagenas 900 mikrog/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Haemophilus influenzae type B capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid only vaccine product |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Minocycline only product in cutaneous dose form |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Fenfluramine only product in oral dose form |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Remdesivir 5 mg/mL solution for injection |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Remdesivir 5 mg/mL solution for injection |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Soya oil refined only product in parenteral dose form |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing only soya oil refined (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely agomelatine (as agomelatine citric acid) 25 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely agomelatine (as agomelatine citric acid) 25 milligram/1 each conventional release oral tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Carbon (13-C) urea only product |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing only carbon (13-C) urea in oral dose form (medicinal product form) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product |
räkning av aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
SARS-CoV-2 antigen vaccine |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing only bamlanivimab (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Bamlanivimab only product in parenteral dose form |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
SARS-CoV-2 mRNA vaccine |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |